Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.05.02.442326: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The studies were approved by the Institutional Review Board of Vanderbilt University Medical Center.
IACUC: The protocols were approved by the Institutional Animal Care and Use Committee at the Washington University School of Medicine (assurance number A3381–01).Sex as a biological variable We studied one patient (a 59-year-old male) who received Pfizer-BioNTech vaccine. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication Contamination: Mycoplasma testing of cell lines was performed on monthly basis using a PCR-based mycoplasma detection kit (ATCC, 30-1012K), with negative results at each testing. Table 2: Resources
Antibodies Sentences Resources Bou… SciScore for 10.1101/2021.05.02.442326: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The studies were approved by the Institutional Review Board of Vanderbilt University Medical Center.
IACUC: The protocols were approved by the Institutional Animal Care and Use Committee at the Washington University School of Medicine (assurance number A3381–01).Sex as a biological variable We studied one patient (a 59-year-old male) who received Pfizer-BioNTech vaccine. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication Contamination: Mycoplasma testing of cell lines was performed on monthly basis using a PCR-based mycoplasma detection kit (ATCC, 30-1012K), with negative results at each testing. Table 2: Resources
Antibodies Sentences Resources Bound antibodies were detected using goat anti-human IgG conjugated with horseradish peroxidase and TMB substrate. anti-human IgGsuggested: NoneAntibody binding was detected with anti-IgG Alexa-Fluor-647-labelled secondary antibodies. anti-IgG Alexa-Fluor-647-labelled secondary antibodies.suggested: NoneACE2 binding was detected using HRP-conjugated anti-FLAG antibodies and developed with TMB substrate. anti-FLAGsuggested: NonePrimary J2 anti-dsRNA (Scicons #10010500) antibody solution at a 1:1,000 dilution was placed on the cells overnight at 4°C. anti-dsRNAsuggested: (SCICONS Cat# 10010200, RRID:AB_2651015)Cells were washed with 0.1% Tween-20/PBS (PBST) three times and plates were incubated with secondary goat anti-mouse Alexa-Fluor-546-labeled antibody at 1:1,000 dilution (Thermo Fisher Scientific) for 2 h at room temperature in the dark. anti-mousesuggested: NoneEnriched cells were stained 30 min on ice in a RoboSep buffer (StemCell Technologies) containing following phenotyping antibodies; anti-CD19-FITC (1:20 dilution, eBioscience), anti-CD27-APC (1:20 dilution), and anti-CD38-PE (1:25 dilution, BD Biosciences), and then analyzed by flow cytometry using an SH800 cell sorter (Sony). anti-CD19-FITCsuggested: (Millipore Cat# FCMAB218F, RRID:AB_10919255)anti-CD27-APCsuggested: (Sigma-Aldrich Cat# SAB4700132, RRID:AB_10896618)anti-CD38-PEsuggested: (Sigma-Aldrich Cat# P6722, RRID:AB_261136)ELISpot assay: Direct enzyme-linked immunosorbent spot (ELISpot) assay was performed to enumerate plasmablasts present in the PBMC samples secreting IgG, IgM, or IgA antibodies reacting with either SARS-CoV-2-S6Pecto protein or influenza A/Darwin/42/2020 H1N1 hemagglutinin protein (as a negative control). IgAsuggested: NoneH1N1 hemagglutinin proteinsuggested: NonePlates were washed with PBS and then PBS containing 0.05% Tween, and then incubated with either goat anti-human IgG-HRP conjugated antibodies (Southern Biotech), goat anti-human IgA-HRP conjugated antibodies (Southern Biotech), or goat anti-human IgM-HRP conjugated antibodies (Southern Biotech) for 2 h at room temperature. anti-human IgG-HRPsuggested: (SouthernBiotech Cat# 2040-05, RRID:AB_2795644)anti-human IgM-HRPsuggested: NonePlates were washed with PBS and then PBS containing 0.05% Tween, and then incubated with either goat anti-human IgG-HRP conjugated antibodies (Southern Biotech, catalog no. 2040-05), goat anti-human IgA-HRP conjugated antibodies (Southern Biotech, catalog no. 2050-05), or goat anti-human IgM-HRP conjugated antibodies (Southern Biotech, catalog no. 2020-05) for 2 h at room temperature. anti-human IgA-HRPsuggested: (SouthernBiotech Cat# 2050-05, RRID:AB_2687526)Experimental Models: Cell Lines Sentences Resources Cell lines: Vero E6 (ATCC, CRL-1586) cells were maintained at 37°C in 5% CO2 in Dulbecco’s minimal essential medium (DMEM) containing 10% heat inactivated fetal bovine serum (FBS), 10 mM HEPES pH 73, 1 mM sodium pyruvate, 1× non-essential amino acids, and 100 U/mL of penicillin-streptomycin. Vero E6suggested: NoneCalu-3 (ATCC, HTB-55) cells were maintained at 37°C in 5% CO2 in DMEM with high glucose and L-glutamine (Gibco 11965092), containing 10% heat inactivated fetal bovine serum (FBS), and 100 U/mL of penicillin-streptomycin. Calu-3suggested: ATCC Cat# HTB-55, RRID:CVCL_0609)Infectious stocks were propagated by inoculating Vero CCL81 cells. Vero CCL81suggested: NoneCell-surface antigen-display assay: Vero cell monolayers were monitored until 80% confluent and then inoculated with VSV-SARS-CoV-2 V (WA1/2020 strain) at an MOI of 0.5 in culture medium (DMEM with 2% FBS). Verosuggested: NoneA plasmid encoding cDNA for each S protein mutant was transfected into HEK-293T cells and allowed to express for 22 h. HEK-293Tsuggested: NoneExperimental Models: Organisms/Strains Sentences Resources Heterozygous K18-hACE c57BL/6J mice (strain: 2B6.Cg-Tg(K18-ACE2)2Prlmn/J) were obtained from The Jackson Laboratory. K18-hACE c57BL/6Jsuggested: NoneSoftware and Algorithms Sentences Resources Heat map generation: All sequences that were identified to be public clonotypes were analyzed with PyIR66 to identify the V and J genes. PyIR66suggested: NoneThese frequency counts then were plotted onto the heatmap using Python Seaborn Library. Pythonsuggested: (IPython, RRID:SCR_001658)Expressed protein was incubated with BioLock (IBA Lifesciences) and then isolated by Strep-tag affinity chromatography on StrepTrap HP columns (GE Healthcare), followed by size-exclusion chromatography on TSKgel G4000SWXL (TOSOH) if needed. BioLocksuggested: NoneBriefly, a TaqMan assay was designed to target a highly conserved region of the N gene (forward primer: ATGCTGCAATCGTGCTACAA; Reverse primer:m GACTGCCGCCTCTGCTC; Probe: /56-FAM/TCAAGGAAC/ZEN/AACATTGCCAA/3IABkFQ/). GACTGCCGCCTCTGCTCsuggested: NoneProbesuggested: (UniPROBE, RRID:SCR_005803)Image processing was performed using the cryoSPARC software package. cryoSPARCsuggested: (cryoSPARC, RRID:SCR_016501)Enriched cells were stained 30 min on ice in a RoboSep buffer (StemCell Technologies) containing following phenotyping antibodies; anti-CD19-FITC (1:20 dilution, eBioscience), anti-CD27-APC (1:20 dilution), and anti-CD38-PE (1:25 dilution, BD Biosciences), and then analyzed by flow cytometry using an SH800 cell sorter (Sony). BD Biosciencessuggested: (BD Biosciences, RRID:SCR_013311)Amplicons were sequenced on an Illumina Novaseq 6000, and data were processed using the CellRanger software v3.1.0 (10X Genomics). CellRangersuggested: (SCIGA, RRID:SCR_021002)Statistical analyses were performed using Prism v8.4.3 (GraphPad). Prismsuggested: (PRISM, RRID:SCR_005375)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-